Silke Laßmann

4.1k citations

87 papers · 2.7k indexed · h-index 31

Impact in

Oncology top 2%
- Cancer-related Molecular Pathways
- Colorectal Cancer Treatments and Studies
Cancer Research top 5%

Papers in ⓘ

Oncology 42
- Cancer-related Molecular Pathways 9
- Colorectal Cancer Treatments and Studies 9
- HER2/EGFR in Cancer Research 5
Cancer Research 16
- Cancer Genomics and Diagnostics 9

Co-authors: Martin Werner (55 shared papers)Ulrich T. Hopt (10 shared papers)Axel Walch (10 shared papers)Uta Jütting (5 shared papers)Frank Makowiec (6 shared papers)Heinz Höfler (6 shared papers)Iain L. Campbell (3 shared papers)Annette Hasenburg (6 shared papers)
Journals: Journal of Molecular Medicine (4 papers)Clinical Cancer Research (3 papers)The Journal of Pathology (3 papers)Oncotarget (3 papers)British Journal of Cancer (3 papers)
Partner nations: Germany United States Switzerland

In The Last Decade

Silke Laßmann

86 papers receiving 2.6k citations

Peers

Countries citing papers authored by Silke Laßmann

Since Specialization

Citations

This map shows the geographic impact of Silke Laßmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silke Laßmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silke Laßmann more than expected).

Fields of papers citing papers by Silke Laßmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silke Laßmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silke Laßmann. The network helps show where Silke Laßmann may publish in the future.

Co-authors

The 25 scholars most cited alongside Silke Laßmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Silke Laßmann Line = papers co-authored together Silke Laßmann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Aurora Kinase A Messenger RNA Overexpression Is Correlated with Tumor Progression and Shortened Survival in Head and Neck Squamous Cell Carcinoma Clinical Cancer Research ·Rudolf Reiter, P. Gais, Uta Jütting, Miriam K. Steuer-Vogt, Anja Pickhard, Karin Bink, Sandra Rauser, Silke Laßmann, Heinz Höfler, Martin Werner, Axel Walch	2006	169
2	The Activation Status of Neuroantigen-specific T Cells in the Target Organ Determines the Clinical Outcome of Autoimmune Encephalomyelitis The Journal of Experimental Medicine ·Naoto Kawakami, Silke Laßmann, Zhaoxia Li, Francesca Odoardi, Thomas Ritter, Tjalf Ziemssen, Wolfgang E. F. Klinkert, Joachim W. Ellwart, Monika Bradl, Kimberly Krivacic, Hans Lassmann, Richard M. Ransohoff, Hans‐Dieter Volk, Hartmut Wekerle, Christopher Linington, Alexander Flügel	2004	151
3	Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas Journal of Molecular Medicine ·Silke Laßmann, Roland Weís, Frank Makowiec, Jasmine Roth, Mihai Danciu, Ulrich T. Hopt, Martin Werner	2006	124
4	Alpha-folate receptor expression in epithelial ovarian carcinoma and non-neoplastic ovarian tissue. PubMed ·Susanne Markert, Silke Laßmann, Boris Gabriel, Maximilian Klar, Martin Werner, G. Gitsch, Felix Kratz, Annette Hasenburg	2009	103
5	STAT3 mRNA and protein expression in colorectal cancer: effects on STAT3-inducible targets linked to cell survival and proliferation Journal of Clinical Pathology ·Silke Laßmann, Ingrid Schuster, Axel Walch, Heike Göbel, Uta Jütting, Frank Makowiec, Ulrich T. Hopt, Martin Werner	2007	99
6	Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytes British Journal of Cancer ·M. Stumpf, Annette Hasenburg, M-O Riener, Uta Jütting, Cheng Wang, Yijun Shen, Marzenna Orlowska‐Volk, Paul Fisch, Zhishan Wang, G. Gitsch, Martin Werner, Silke Laßmann	2009	93
7	Fibroblast activation protein‐α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations Molecular Oncology ·Maria Magdalena Koczorowska, Stefan Tholen, Felicitas Bucher, Lisa Lutz, Jayachandran N. Kizhakkedathu, Olivier De Wever, Ulrich F. Wellner, Martin L. Biniossek, Andreas Stahl, Silke Laßmann, Oliver Schilling	2015	87
8	C10 Is a Novel Chemokine Expressed in Experimental Inflammatory Demyelinating Disorders that Promotes Recruitment of Macrophages to the Central Nervous System American Journal Of Pathology ·Valérie C. Asensio, Silke Laßmann, Axel Pagenstecher, Scott C. Steffensen, Steven J. Henriksen, Iain L. Campbell	1999	87
9	Astrocyte-Targeted Expression of IL-12 Induces Active Cellular Immune Responses in the Central Nervous System and Modulates Experimental Allergic Encephalomyelitis The Journal of Immunology ·Axel Pagenstecher, Silke Laßmann, Monica J. Carson, Carrie Kincaid, Anna K. Stalder, Iain L. Campbell	2000	86
10	Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine Epigenetics ·Theresa D. Ahrens, Sylvia Timme, Jens Hoeppner, Jenny Ostendorp, Sina Hembach, Marie Follo, Ulrich T. Hopt, Martin Werner, Hauke Busch, Melanie Boerries, Silke Laßmann	2015	63
11	Predictive Value of Aurora-A/STK15 Expression for Late Stage Epithelial Ovarian Cancer Patients Treated by Adjuvant Chemotherapy Clinical Cancer Research ·Silke Laßmann, Yijun Shen, Uta Jütting, Philipp Wiehle, Axel Walch, G. Gitsch, Annette Hasenburg, Martin Werner	2007	61
12	Identification of gene signatures for invasive colorectal tumor cells Cancer Detection and Prevention ·Anja Wiese, Johannes Auer, Silke Laßmann, Jörg Nährig, Robert Rosenberg, Heinz Höfler, Rüdiger Rüger, Martin Werner	2007	53
13	EGFR, HER2 and HER3 dimerization patterns guide targeted inhibition in two histotypes of esophageal cancer International Journal of Cancer ·Christiane D. Fichter, Sylvia Timme, Julia A. Braun, Verena Gudernatsch, Anja Schöpflin, Lioudmilla Bogatyreva, Helene Geddert, Gerhard Faller, David S. Klimstra, Laura H. Tang, Dieter Hauschke, Martin Werner, Silke Laßmann	2014	53
14	STAT3 expression, activity and functional consequences of STAT3 inhibition in esophageal squamous cell carcinomas and Barrett’s adenocarcinomas Oncogene ·Sylvia Timme, S Ihde, Christiane D. Fichter, Verena Waehle, Lioudmilla Bogatyreva, Kostadin E. Atanasov, Ines Köhler, Anja Schöpflin, Helene Geddert, Gerhard Faller, David S. Klimstra, Laura H. Tang, Thomas Reinheckel, Dieter Hauschke, Hauke Busch, Melanie Boerries, Martin Werner, Silke Laßmann	2013	48
15	Insulin-like growth factor-I treatment reduces immune cell responses in acute non-demyelinative experimental autoimmune encephalomyelitis Journal of Neuroscience Research ·Xuwen Liu, Christopher Linnington, H. deF. Webster, Silke Laßmann, D. -L. Yao, Lynn D. Hudson, Hartmut Wekerle, G. W. Kreutzberg	1997	43
16	B-Raf Inhibitors Induce Epithelial Differentiation in BRAF -Mutant Colorectal Cancer Cells Cancer Research ·Ricarda Herr, M. Köhler, Hana Andrlová, Florian Weinberg, Yvonne Möller, Sebastian Halbach, Lisa Lutz, Justin Mastroianni, Martin Klose, Nicola Bittermann, Silke Kowar, Robert Zeiser, Monilola A. Olayioye, Silke Laßmann, Hauke Busch, Melanie Boerries, Tilman Brummer	2014	42
17	Harnessing CD3 diversity to optimize CAR T cells Nature Immunology ·Rubí M.-H. Velasco Cárdenas, Simon M. Brandl, Ana Valeria Meléndez, Alexandra Emilia Schlaak, Annabelle Buschky, Timo Peters, Fabian Beier, Bryan Serrels, Sanaz Taromi, Katrin Raute, Simon Hauri, Matthias Gstaiger, Silke Laßmann, Johannes B. Huppa, Melanie Boerries, Geoffroy Andrieux, Bertram Bengsch, Wolfgang W. Schamel, Susana Minguet	2023	42
18	Surgical management of lower-grade glioma in the spotlight of the 2016 WHO classification system Journal of Neuro-Oncology ·Daniel Delev, Dieter Henrik Heiland, Pamela Franco, Peter C. Reinacher, Irina Mader, Ori Staszewski, Silke Laßmann, Stefan Grau, Oliver Schnell	2018	42
19	Gab2 signaling in chronic myeloid leukemia cells confers resistance to multiple Bcr-Abl inhibitors Leukemia ·Franziska U. Wöhrle, Sebastian Halbach, Konrad Aumann, Sven Schwemmers, Sandra Braun, Patrick Auberger, Daniel Schramek, Josef Penninger, Silke Laßmann, Martin Werner, Cornelius F. Waller, Heike L. Pahl, Robert Zeiser, Roger J. Daly, Tilman Brummer	2012	42
20	Occurrence of multipolar mitoses and association with Aurora-A/-B kinases and p53 mutations in aneuploid esophageal carcinoma cells BMC Cell Biology ·Christiane D. Fichter, Corinna Herz, Claudia Münch, Oliver G. Opitz, Martin Werner, Silke Laßmann	2011	39

About Silke Laßmann

Silke Laßmann is a scholar working on Oncology, Cancer Research, Cell Biology, Pathology and Forensic Medicine and Genetics, having authored 87 papers that have together received 2.7k indexed citations. Recurring topics across this work include Microtubule and mitosis dynamics (14 papers), Genetic factors in colorectal cancer (10 papers), Cancer Genomics and Diagnostics (9 papers), Cancer-related Molecular Pathways (9 papers), Colorectal Cancer Treatments and Studies (9 papers), Molecular Biology Techniques and Applications (7 papers), Lung Cancer Treatments and Mutations (6 papers) and HER2/EGFR in Cancer Research (5 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (431 citations), Pathology and Forensic Medicine (387 citations), Immunology (453 citations) and Cell Biology (346 citations). Silke Laßmann has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Martin Werner, Ulrich T. Hopt, Axel Walch, Uta Jütting, Frank Makowiec, Heinz Höfler, Iain L. Campbell, Annette Hasenburg, G. Gitsch and Axel Pagenstecher. Their work appears in journals such as Journal of Molecular Medicine, Clinical Cancer Research, The Journal of Pathology, Oncotarget and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact